Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Funding boost for thoroughbred breeding research
Scientists believe that early life experiences can alter a horse's susceptibility to disease in later life.
Scientists will study the impact of early-life experiences on performance.

Researchers at the Royal Veterinary College (RVC) have been awarded funding to study the early-life influences on the performance and financial viability of Thoroughbred breeding.

Understood to be the first study of its kind in the UK, scientists hope the research will improve athletic performance and strengthen stud farm sustainability. 

In the study, funded by the Horserace Betting Levy Board and the Racing Foundation, Dr Rebecca Mouncey and her team will analyse information from a group of young Thoroughbreds born in 2019 and 2020. 

As part of the ongoing research set up during Rebecca's PhD, the horses have been monitored since birth, and records of their breeding and veterinary histories, the turn-out and exercise they received, any episodes of sickness or injury, and routine procedures like farriery have been kept.

Using these exposures, alongside financial data and evaluating sales, training and racing outcomes, the team aims to: 

describe the proportions of horses that enter training and race, including reasons and destinations of any that do not
evaluate the effects of early-life health and exercise on horses’ training and racing performance
calculate costs of production and evaluate stud farm profitability 
assess the financial impact of early-life disease and injury. 

Scientists believe that early life experiences can alter a horse's susceptibility to disease in later life – a theory that has been proven in studies of humans.

While data suggest there has been little change in the number of horses entering training or winning prize money over the last twenty years, there is little evidence to explain why some horses fail to achieve these milestones. 

Researchers say it is timely to address these knowledge gaps, particularly around the costs of disease and injury, especially given the current economic climate in which, they report, a rising number of Thoroughbred breeders are unprofitable.

Dr Mouncey, a veterinary surgeon and post-doctoral researcher at the RVC, said: “Musculoskeletal disease and injury remain the greatest barrier to Thoroughbreds being retained within the industry and realising their maximum athletic potential and is likely to have important economic consequences, particularly in the current financial climate. 

“Our study will provide vital and directly applicable information at both horse- and farm-level, evaluating the influence of early-life management and health on production costs, profitability and racing performance in Thoroughbreds.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.